These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 19969344)
41. Ocular iontophoretic supplementation of intravenous foscarnet therapy. Yoshizumi MO; Roca JA; Lee DA; Lee G; Gomez I Am J Ophthalmol; 1996 Jul; 122(1):86-90. PubMed ID: 8659602 [TBL] [Abstract][Full Text] [Related]
42. Transscleral iontophoresis of foscarnet. Sarraf D; Equi RA; Holland GN; Yoshizumi MO; Lee DA Am J Ophthalmol; 1993 Jun; 115(6):748-54. PubMed ID: 8389526 [TBL] [Abstract][Full Text] [Related]
43. Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate. Kunou N; Ogura Y; Honda Y; Hyon SH; Ikada Y J Biomed Mater Res; 2000 Sep; 51(4):635-41. PubMed ID: 10880111 [TBL] [Abstract][Full Text] [Related]
44. Effect of Biodegradable Scleral Plugs Containing Curcumin on Proliferative Vitreoretinopathy. Zhang J; Zhou N; Zhang B; Ma J Ophthalmic Res; 2018; 59(1):30-36. PubMed ID: 28942445 [TBL] [Abstract][Full Text] [Related]
45. Severe bacterial endophthalmitis: towards improving clinical outcomes. Novosad BD; Callegan MC Expert Rev Ophthalmol; 2010 Oct; 5(5):689-698. PubMed ID: 21572565 [TBL] [Abstract][Full Text] [Related]
46. In vitro elution of vancomycin/amikacin/steroid from solvent-free biodegradable scleral plugs. Liu SJ; Kau YC; Liaw CW; Peng YJ Int J Pharm; 2009 Mar; 370(1-2):75-80. PubMed ID: 19101617 [TBL] [Abstract][Full Text] [Related]
47. Scleral plug of biodegradable polymers containing ganciclovir for experimental cytomegalovirus retinitis. Sakurai E; Matsuda Y; Ozeki H; Kunou N; Nakajima K; Ogura Y Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2043-8. PubMed ID: 11481270 [TBL] [Abstract][Full Text] [Related]
48. Foscarnet and ganciclovir pharmacokinetics during concomitant or alternating maintenance therapy for AIDS-related cytomegalovirus retinitis. Aweeka FT; Gambertoglio JG; Kramer F; van der Horst C; Polsky B; Jayewardene A; Lizak P; Emrick L; Tong W; Jacobson MA Clin Pharmacol Ther; 1995 Apr; 57(4):403-12. PubMed ID: 7712668 [TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical localization of ganciclovir in the human retina. Park SS; Girard B; Font RL; Hauw JJ; Young LH Curr Eye Res; 1998 Jun; 17(6):663-7. PubMed ID: 9663857 [TBL] [Abstract][Full Text] [Related]
50. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir. Jabs DA Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191 [TBL] [Abstract][Full Text] [Related]
51. New treatment options for CMV retinitis in AIDS. Lalezari JP Adv Nurse Pract; 1997 Apr; 5(4):45-9, 83. PubMed ID: 9459896 [No Abstract] [Full Text] [Related]
52. Cytomegalovirus retinitis in persons with AIDS. Selecting therapy for a sight-threatening disease. Balfour HH Postgrad Med; 1995 Jan; 97(1):109-13, 117-8. PubMed ID: 7816708 [TBL] [Abstract][Full Text] [Related]
53. Sustained release of ganciclovir and foscarnet from biodegradable scleral plugs for the treatment of cytomegalovirus retinitis. Peng YJ; Wen CW; Chiou SH; Liu SJ Biomaterials; 2010 Mar; 31(7):1773-9. PubMed ID: 19969344 [TBL] [Abstract][Full Text] [Related]